BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12418503)

  • 1. S-adenosyl-L-methionine: its role in the treatment of liver disorders.
    Lieber CS
    Am J Clin Nutr; 2002 Nov; 76(5):1183S-7S. PubMed ID: 12418503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases.
    Lieber CS
    Adv Pharmacol; 1997; 38():601-28. PubMed ID: 8895826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings.
    Lieber CS
    Alcohol; 2002 Jul; 27(3):173-7. PubMed ID: 12163146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D
    Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years.
    Lieber CS
    Rocz Akad Med Bialymst; 2005; 50():7-20. PubMed ID: 16363067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments.
    Lieber CS
    Curr Gastroenterol Rep; 2004 Feb; 6(1):60-5. PubMed ID: 14720455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats.
    Feo F; Pascale R; Garcea R; Daino L; Pirisi L; Frassetto S; Ruggiu ME; Di Padova C; Stramentinoli G
    Toxicol Appl Pharmacol; 1986 Apr; 83(2):331-41. PubMed ID: 2938307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease.
    Vendemiale G; Altomare E; Trizio T; Le Grazie C; Di Padova C; Salerno MT; Carrieri V; Albano O
    Scand J Gastroenterol; 1989 May; 24(4):407-15. PubMed ID: 2781235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALCOHOL: its metabolism and interaction with nutrients.
    Lieber CS
    Annu Rev Nutr; 2000; 20():395-430. PubMed ID: 10940340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view.
    Testino G; Leone S; Ansaldi F; Borro P
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):341-56. PubMed ID: 24212353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [S-adenosyl-L-methionine (SAMe) and its use in hepatology].
    Frezza M; Terpin MM; Peri A
    Minerva Gastroenterol Dietol; 1992; 38(3):145-51. PubMed ID: 1299337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of S-adenosyl-L-methionine on liver damage in experimental obstructive jaundice.
    Tsai SM; Lee KT; Tsai LY
    Kaohsiung J Med Sci; 2001 Sep; 17(9):455-60. PubMed ID: 11842648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury.
    Martínez-Chantar ML; García-Trevijano ER; Latasa MU; Pérez-Mato I; Sánchez del Pino MM; Corrales FJ; Avila MA; Mato JM
    Am J Clin Nutr; 2002 Nov; 76(5):1177S-82S. PubMed ID: 12418501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?
    Osman E; Owen JS; Burroughs AK
    Aliment Pharmacol Ther; 1993 Feb; 7(1):21-8. PubMed ID: 8439634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD002235. PubMed ID: 26560497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alleviation of alcoholic liver injury by betaine involves an enhancement of antioxidant defense via regulation of sulfur amino acid metabolism.
    Jung YS; Kim SJ; Kwon DY; Ahn CW; Kim YS; Choi DW; Kim YC
    Food Chem Toxicol; 2013 Dec; 62():292-8. PubMed ID: 23994088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 18. Glutathione in the treatment of liver diseases: insights from clinical practice.
    Sacco R; Eggenhoffner R; Giacomelli L
    Minerva Gastroenterol Dietol; 2016 Dec; 62(4):316-324. PubMed ID: 27603810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adenosyl-methionine in alcoholic liver disease and intrahepatic cholestasis.
    Testino G; Leone S; Fagoonee S; Pellicano R
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):187-189. PubMed ID: 29521488
    [No Abstract]   [Full Text] [Related]  

  • 20. S-adenosylmethionine attenuates oxidative liver injury in micropigs fed ethanol with a folate-deficient diet.
    Villanueva JA; Esfandiari F; White ME; Devaraj S; French SW; Halsted CH
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1934-43. PubMed ID: 17850216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.